Clinical trial
A Questionnaire Study by Elevated Prostate Specific Antigen (PSA): Do Men Where Subsequent Assessment Shows Prostate Cancer, Higher Levels of Neuroticism and Stress Compared to Those Who do Not Get the Diagnosis?
NCT02031029 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Questionnaire Study by Elevated Prostate Specific Antigen (PSA): Do Men Where Subsequent Assessment Shows Prostate Cancer, Higher Levels of Neuroticism and Stress Compared to Those Who do Not Get the Diagnosis?
- Lead sponsor
- Helse Stavanger HF
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 31, 2013
- Completion date
- December 18, 2015
- Enrollment
- 51 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.